This statistic shows the development of the R&D spending of Dutch biotech company Qiagen from 2012 to 2023. In 2023, R&D spending of this company stood at some 199 million U.S. dollars, almost same as in the year before. Qiagen N.V. is headquartered in the Netherlands and in Germany, and is operating in many countries around the world. The company is specialized on sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Qiagen. (March 1, 2024). R&D spending of biotech company Qiagen from 2012 to 2023 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 21, 2026, from /statistics/726743/qiagen-randd-spending/
Qiagen. "R&D spending of biotech company Qiagen from 2012 to 2023 (in million U.S. dollars)." Chart. March 1, 2024. ÌÇÐÄÆƽâ°æ. Accessed July 21, 2026. /statistics/726743/qiagen-randd-spending/
Qiagen. (2024). R&D spending of biotech company Qiagen from 2012 to 2023 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 21, 2026. /statistics/726743/qiagen-randd-spending/
Qiagen. "R&d Spending of Biotech Company Qiagen from 2012 to 2023 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 1 Mar 2024, /statistics/726743/qiagen-randd-spending/
Qiagen, R&D spending of biotech company Qiagen from 2012 to 2023 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/726743/qiagen-randd-spending/ (last visited July 21, 2026)
R&D spending of biotech company Qiagen from 2012 to 2023 (in million U.S. dollars) [Graph], Qiagen, March 1, 2024. [Online]. Available: /statistics/726743/qiagen-randd-spending/
